In a recent article from Forbes, the worst performing biotech stocks from 2013 were listed. Of the companies that posted negative results, the worst damage came to those that presented bad clinical data or had run-ins with the U.S. Food and Drug Administration.
The Worst-Performing Biotech Stocks of 2013
CLSN Celsion Corporation 52.9 -89.4
ASTM Aastrom Biosciences, Inc. 14.1 -87.2
DCTH Delcath Systems, Inc. 32.2 -79.3
CVM CEL-SCI Corporation 28.9 -78.1
AVEO AVEO Pharmaceuticals, Inc. 94.9 -77.3
AMRN Amarin Corporation Plc Sponsored ADR 340.1 -75.6
ENZN Enzon Pharmaceuticals, Inc. 51.1 -73.8
ZLCS Zalicus Inc. 29.0 -71.5
ECTE Echo Therapeutics, Inc. 33.1 -69.8
SPHS Sophiris Bio Inc. 59.8 -68.9
PBMD Prima Biomed Ltd Sponsored ADR 45.1 -68.6
PTX Pernix Therapeutics Holdings, Inc. 93.7 -67.5
OXBT Oxygen Biotherapeutics, Inc. 47.8 -65.1
ARIA ARIAD Pharmaceuticals, Inc. 1,266.2 -64.4
GTXI GTx, Inc. 104.3 -60.7
INFI Infinity Pharmaceuticals, Inc. 664.1 -60.5
ONCY Oncolytics Biotech Inc. 131.4 -60.5
VICL Vical Incorporated 102.4 -59.5
BAXS Baxano Surgical, Inc. 45.6 -59.3
ACHN Achillion Pharmaceuticals, Inc. 320.8 -58.6
BTK AMEX Biotechnology Index 0.0 50.6
If your broker/financial advisor recommend any of these biotechs and did lost more than $50,000, call for a free consultation with an attorney on how to potentially recover your investment losses: 888-760-6552. Soreide Law Group represents clients nationwide in arbitrations before FINRA.
Investors might have sustained financial harm through WestPark Capital Inc. [CRD: 39914, Los Angeles, California], according to publicly available information found on Financial Industry Regulatory Authority BrokerCheck. WestPark Capital has been registered with FINRA since 1996 and maintains its headquarters in Los Angeles, California. Keep reading to discover more about the regulatory action involving the […]
Investors might have sustained losses due to securities broker James Fredrick Tighe [CRD: 3129233, Phoenix, Arizona], and Financial Industry Regulatory Authority barred him, based on public information on BrokerCheck. Tighe was associated with Morgan Stanley from June 1, 2009, through January 14, 2025. Continue reading to find out more about Tighe’s regulatory and client dispute […]
Investors potentially experienced sales practice violations by securities broker Sung Moo Cho (also known as Sam Cho) [CRD: 5015906, New York, New York], and FINRA barred him, given the public information found on FINRA BrokerCheck. Cho was associated with Ameriprise Financial Services from January 22, 2021, to October 21, 2025, and Citigroup Global Markets from […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com